Dilation Device Treats Persistent Eustachian Tube Dysfunction
|
By HospiMedica International staff writers Posted on 26 Sep 2016 |

Image: Eustachian tube balloon dilation with the Aera system (Photo courtesy of Dr. Jeeve Kanagalingam).
A novel dilation system uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pain and other sensations affect the ear.
The Aera Eustachian tube system consists of a balloon catheter that is inserted through the patient’s nose into the Eustachian tube. After insertion, the balloon is inflated for two minutes to open up a pathway for mucus and air to flow through, in order to restore proper function and reduce pressure, pain, or clogged or muffled sensations in the ear. After the Eustachian tube is dilated, the balloon is deflated and removed. The most common adverse events are small tears of the lining of the Eustachian tube, minor bleeding, and worsening of ETD.
In a study involving 299 patients with chronic ETD, 52% of the patients treated with the Aera system had a subsequent normal functioning range as measured by a tympanogram, a method used to measure mobility of the ear drum and pressure inside the ear. The positive results were fourfold higher than in patients treated with conventional medical management using nasal sprays. The Aera system is a product of Acclarent (Menlo Park, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“The Aera Eustachian tube balloon dilation system is a new treatment option for patients with ETD symptoms,” said Malvina Eydelman, MD, director of the ophthalmic & ENT device division at the FDA Center for Devices & Radiological Health (CDRH). “The Eustachian tube supports hearing by maintaining pressure inside the ear. Restoring function to this important part of the middle ear may provide relief from the pain, discomfort and sensation of ear fullness or blockage associated with ETD.”
“The Acclarent Aera offers a minimally-invasive and promising option for patients suffering from Eustachian tube dysfunction," said Juha Silvola, MD, PhD, a consultant in Otology-Otoneurology at Oslo University Hospital (Norway). “In my initial experiences with the Aera, the device enabled me to safely and successfully dilate my patients' Eustachian tubes.”
The Eustachian tube is a narrow passage leading from the pharynx to the cavity of the middle ear, permitting the equalization of pressure on each side of the eardrum. It is normally filled with air and helps maintain equal pressure inside the ear with the surrounding environment by periodically opening and closing, like a valve. If this function is impaired, as is the case with ETD, it results in discomfort, impaired hearing, persistent ear infections, ringing in the ears (tinnitus) or other symptoms.
Related Links:
Acclarent
Oslo University Hospital
The Aera Eustachian tube system consists of a balloon catheter that is inserted through the patient’s nose into the Eustachian tube. After insertion, the balloon is inflated for two minutes to open up a pathway for mucus and air to flow through, in order to restore proper function and reduce pressure, pain, or clogged or muffled sensations in the ear. After the Eustachian tube is dilated, the balloon is deflated and removed. The most common adverse events are small tears of the lining of the Eustachian tube, minor bleeding, and worsening of ETD.
In a study involving 299 patients with chronic ETD, 52% of the patients treated with the Aera system had a subsequent normal functioning range as measured by a tympanogram, a method used to measure mobility of the ear drum and pressure inside the ear. The positive results were fourfold higher than in patients treated with conventional medical management using nasal sprays. The Aera system is a product of Acclarent (Menlo Park, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“The Aera Eustachian tube balloon dilation system is a new treatment option for patients with ETD symptoms,” said Malvina Eydelman, MD, director of the ophthalmic & ENT device division at the FDA Center for Devices & Radiological Health (CDRH). “The Eustachian tube supports hearing by maintaining pressure inside the ear. Restoring function to this important part of the middle ear may provide relief from the pain, discomfort and sensation of ear fullness or blockage associated with ETD.”
“The Acclarent Aera offers a minimally-invasive and promising option for patients suffering from Eustachian tube dysfunction," said Juha Silvola, MD, PhD, a consultant in Otology-Otoneurology at Oslo University Hospital (Norway). “In my initial experiences with the Aera, the device enabled me to safely and successfully dilate my patients' Eustachian tubes.”
The Eustachian tube is a narrow passage leading from the pharynx to the cavity of the middle ear, permitting the equalization of pressure on each side of the eardrum. It is normally filled with air and helps maintain equal pressure inside the ear with the surrounding environment by periodically opening and closing, like a valve. If this function is impaired, as is the case with ETD, it results in discomfort, impaired hearing, persistent ear infections, ringing in the ears (tinnitus) or other symptoms.
Related Links:
Acclarent
Oslo University Hospital
Latest Surgical Techniques News
- Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
- Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
Accurately determining whether a coronary stenosis limits blood flow is essential to guide percutaneous coronary intervention, yet wire-based physiologic testing remains underused due to added procedural... Read more
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







